Back to Gastroenterology
Gastroenterologyv2005Evidence-Based

Montreal Classification for Inflammatory Bowel Disease (IBD)

Classifies phenotype and severity of Crohn's disease and ulcerative colitis to guide treatment decisions and predict disease course.

Clinical Input Parameters

years
Range: 0 — 120 years
Clinical Assessment
Awaiting Parameters
montreal classification
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Montreal Classification for Inflammatory Bowel Disease (IBD) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

For Crohn's Disease: A[age] + L[location] + B[behavior] + p[perianal]. For Ulcerative Colitis: A[age] + E[extent] + S[severity]. Age: A1 (<17y), A2 (17-40y), A3 (>40y).

Clinical Pearls & Practice Notes

  • Montreal Classification replaced Vienna Classification in 2005
  • Provides standardized phenotypic characterization for IBD
  • Age categories: A1 (<17 years), A2 (17-40 years), A3 (>40 years)
  • Crohn's location: L1 (ileal), L2 (colonic), L3 (ileocolonic), L4 (upper GI)
  • Crohn's behavior: B1 (inflammatory), B2 (stricturing), B3 (penetrating)
  • Perianal modifier 'p' can be added to any Crohn's behavior
  • UC extent: E1 (proctitis), E2 (left-sided), E3 (extensive/pancolitis)
  • UC severity: S0 (remission), S1 (mild), S2 (moderate), S3 (severe)
  • Classification evolves over time with disease progression
  • Helps predict prognosis and guide treatment strategies
  • Widely used in clinical trials and research
  • Essential for personalized IBD management

Evidence & Literature Citations

  1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5A-36A. doi: 10.1155/2005/269076.
  2. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53. doi: 10.1136/gut.2005.082909.
  3. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010;139(4):1147-55. doi: 10.1053/j.gastro.2010.06.070.

Score Interpretation Ranges

Crohn's Disease Classification≤ pts

Age + Location + Behavior + Perianal modifier

Ulcerative Colitis Classification≤ pts

Age + Extent + Severity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.